Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma

被引:0
|
作者
Burgess, Laura [1 ]
Keenan, Marissa [2 ]
Zhou, Alan Liang [3 ]
Lypka, Kiefer [3 ]
Saraqini, Delvina Hasimja [3 ]
Yao, Jeff [4 ]
Martin, Samuel [5 ]
Morash, Christopher [4 ]
Watterson, James [4 ]
Canil, Christina [6 ]
MacRae, Robert [1 ]
机构
[1] Univ Ottawa, Dept Radiol, Div Radiat Oncol, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
[2] Univ Ottawa, Dept Med, Div Rheumatol, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
[3] Univ Ottawa, Dept Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
[4] Univ Ottawa, Dept Surg, Div Urol, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
[5] Univ Ottawa, Fac Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
[6] Univ Ottawa, Dept Med, Div Med Oncol, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
关键词
stereotactic radiotherapy (SBRT); renal cell carcinoma (RCC); paraneoplastic vasculitis; paraneoplastic syndrome; oligometastases; LEUKOCYTOCLASTIC VASCULITIS;
D O I
10.3390/curroncol28030162
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Approximately 20% of renal cell carcinoma (RCC) is diagnosed because of paraneoplastic manifestations. RCC has been associated with a large variety of paraneoplastic syndromes (PNS), but it is rarely associated with PNS vasculitis. We present a case of a previously healthy male who presented with systemic vasculitis; bitemporal headaches, diplopia, polyarthritis, palpable purpura, tongue lesion, peri-orbital edema, scleritis, chondritis and constitutional symptoms. He was subsequently found to have oligometastatic RCC. Both his primary lesion and site of oligometastasis were treated with stereotactic radiotherapy (SBRT) and resulted in the resolution of his vasculitis, as well as sustained oncologic response. This is the first case to demonstrate that effective sustained treatment for PNS vasculitis due to oligometastatic RCC is possible with SBRT.
引用
收藏
页码:1744 / 1750
页数:7
相关论文
共 50 条
  • [31] A Delphi consensus study on stereotactic body radiotherapy for oligometastatic renal cell carcinoma (RCC), an ESTRO study - with EAU endorsement
    Marvaso, Giulia
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S142 - S142
  • [32] Bone Only Oligometastatic Renal Cell Carcinoma Patients Treated with Stereotactic Body Radiotherapy: A MULTI-Institutional Study
    Onal, C.
    Guler, O. C.
    Hurmuz, P.
    Yavas, G.
    Tilki, B.
    Oymak, E.
    Yavas, C.
    Ozyigit, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E209 - E209
  • [33] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Cem Onal
    Ezgi Oymak
    Ozan Cem Guler
    Burak Tilki
    Guler Yavas
    Pervin Hurmuz
    Cagdas Yavas
    Gokhan Ozyigit
    Strahlentherapie und Onkologie, 2023, 199 : 456 - 464
  • [34] ANCA ASSOCIATED VASCULITIS OR RENAL CELL CARCINOMA ASSOCIATED PARANEOPLASTIC VASCULITIS, WITH A MANAGEMENT ISSUE OF IMMUNOSUPPRESSION
    Ooi, Michael
    Puri, Prianka
    NEPHROLOGY, 2022, 27 : 81 - 81
  • [35] Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma
    Franzese, Ciro
    Franceschini, Davide
    Di Brina, Lucia
    D'Agostino, Giuseppe Roberto
    Navarria, Pierina
    Comito, Tiziana
    Mancosu, Pietro
    Tomatis, Stefano
    Scorsetti, Marta
    JOURNAL OF UROLOGY, 2019, 201 (01): : 70 - 75
  • [36] Should stereotactic radiotherapy be the preferred treatment for oligometastatic disease?
    Palma, David
    Tree, Alison
    LANCET ONCOLOGY, 2021, 22 (08): : 1067 - 1068
  • [37] Role of stereotactic radiotherapy in the treatment of oligometastatic colorectal cancer
    Pouypoudat, C.
    Trouette, R.
    Bernard, B.
    Vendrely, V.
    CANCER RADIOTHERAPIE, 2021, 25 (6-7): : 523 - 525
  • [38] Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
    Takaya Yamamoto
    Noriyuki Kadoya
    Ken Takeda
    Haruo Matsushita
    Rei Umezawa
    Kiyokazu Sato
    Masaki Kubozono
    Kengo Ito
    Yojiro Ishikawa
    Maiko Kozumi
    Noriyoshi Takahashi
    Yu Katagiri
    Hiroshi Onishi
    Keiichi Jingu
    Radiation Oncology, 11
  • [39] Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
    Yamamoto, Takaya
    Kadoya, Noriyuki
    Takeda, Ken
    Matsushita, Haruo
    Umezawa, Rei
    Sato, Kiyokazu
    Kubozono, Masaki
    Ito, Kengo
    Ishikawa, Yojiro
    Kozumi, Maiko
    Takahashi, Noriyoshi
    Katagiri, Yu
    Onishi, Hiroshi
    Jingu, Keiichi
    RADIATION ONCOLOGY, 2016, 11
  • [40] stereotactic radiotherapy for oligometastatic esophagogastric carcinoma outcome, prognostic factors
    Di Cristina, L.
    Franceschini, D.
    Teriaca, M. A.
    Vernier, V.
    Lo Faro, L.
    Franzese, C.
    Comito, T.
    Clerici, E.
    Bellu, L.
    Dominici, L.
    Spoto, R.
    Massaro, M.
    Navarria, P.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1093 - S1095